Eric C. Woolf

748 total citations
18 papers, 565 citations indexed

About

Eric C. Woolf is a scholar working on Physiology, Cancer Research and Molecular Biology. According to data from OpenAlex, Eric C. Woolf has authored 18 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 10 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in Eric C. Woolf's work include Diet and metabolism studies (13 papers), Cancer, Hypoxia, and Metabolism (10 papers) and Glioma Diagnosis and Treatment (4 papers). Eric C. Woolf is often cited by papers focused on Diet and metabolism studies (13 papers), Cancer, Hypoxia, and Metabolism (10 papers) and Glioma Diagnosis and Treatment (4 papers). Eric C. Woolf collaborates with scholars based in United States, United Kingdom and Canada. Eric C. Woolf's co-authors include Adrienne C. Scheck, Nelofer Syed, John L. Johnson, Danielle M. Lussier, Joseph N. Blattman, Mark C. Preul, Gregory Turner, Qingwei Liu, Leonel Ampie and Christopher Dardis and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Eric C. Woolf

18 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric C. Woolf United States 8 296 238 182 117 73 18 565
Haruko Watanabe‐Takano Japan 15 90 0.3× 342 1.4× 63 0.3× 26 0.2× 21 0.3× 26 629
Lior Roitman Israel 7 224 0.8× 213 0.9× 47 0.3× 18 0.2× 19 0.3× 8 482
Adam Horn United States 11 114 0.4× 454 1.9× 33 0.2× 18 0.2× 33 0.5× 22 649
Donald W. Lawrence United States 11 97 0.3× 211 0.9× 46 0.3× 11 0.1× 19 0.3× 15 545
Kathleen Jee United States 9 24 0.1× 221 0.9× 110 0.6× 25 0.2× 34 0.5× 15 440
Misako Kawahara United States 9 270 0.9× 258 1.1× 67 0.4× 11 0.1× 15 0.2× 9 583
Charles O. Smith United States 13 70 0.2× 266 1.1× 43 0.2× 15 0.1× 27 0.4× 15 409
H. S. Jeffrey Man Canada 11 100 0.3× 364 1.5× 296 1.6× 11 0.1× 24 0.3× 21 664
Jean‐Marie Mussini France 10 257 0.9× 278 1.2× 15 0.1× 23 0.2× 14 0.2× 16 646
Jin Rong Ow Singapore 13 44 0.1× 347 1.5× 56 0.3× 20 0.2× 20 0.3× 20 475

Countries citing papers authored by Eric C. Woolf

Since Specialization
Citations

This map shows the geographic impact of Eric C. Woolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric C. Woolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric C. Woolf more than expected).

Fields of papers citing papers by Eric C. Woolf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric C. Woolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric C. Woolf. The network helps show where Eric C. Woolf may publish in the future.

Co-authorship network of co-authors of Eric C. Woolf

This figure shows the co-authorship network connecting the top 25 collaborators of Eric C. Woolf. A scholar is included among the top collaborators of Eric C. Woolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric C. Woolf. Eric C. Woolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Georges, Joseph, Xiaodong Qi, Xiaowei Liu, et al.. (2020). Provision of rapid and specific ex vivo diagnosis of central nervous system lymphoma from rodent xenograft biopsies by a fluorescent aptamer. Journal of neurosurgery. 134(6). 1783–1790. 4 indexed citations
2.
Zeng, Qingyu, et al.. (2019). The ketogenic diet alters the epigenetic landscape of GBM to potentiate the effects of chemotherapy and radiotherapy. Neuro-Oncology. 21(Supplement_4). iv8–iv8. 6 indexed citations
3.
Belykh, Evgenii, Arpan Patel, Eric J Miller, et al.. (2018). Probe-based three-dimensional confocal laser endomicroscopy of brain tumors: technical note. Cancer Management and Research. Volume 10. 3109–3123. 28 indexed citations
4.
Belykh, Evgenii, Eric J Miller, Nikolay L. Martirosyan, et al.. (2018). Scanning Fiber Endoscope Improves Detection of 5-Aminolevulinic Acid–Induced Protoporphyrin IX Fluorescence at the Boundary of Infiltrative Glioma. World Neurosurgery. 113. e51–e69. 47 indexed citations
5.
Woolf, Eric C.. (2018). Ketogenic Therapy as an Adjuvant for Malignant Glioma:Impacts on Anti-Tumor Immunity. 2 indexed citations
6.
Rutter, Erica M., Jonathan D. Plasencia, Eric C. Woolf, et al.. (2017). Mathematical Analysis of Glioma Growth in a Murine Model. Scientific Reports. 7(1). 2508–2508. 41 indexed citations
7.
Woolf, Eric C., et al.. (2017). Abstract 1125A: β-hydroxybutyrate inhibits histone deacetylase activity and radiosensitizes malignant glioma cells. Cancer Research. 77(13_Supplement). 1125A–1125A. 2 indexed citations
8.
Lussier, Danielle M., et al.. (2016). Enhanced immunity in a mouse model of malignant glioma is mediated by a therapeutic ketogenic diet. BMC Cancer. 16(1). 310–310. 128 indexed citations
9.
Woolf, Eric C., Nelofer Syed, & Adrienne C. Scheck. (2016). Tumor Metabolism, the Ketogenic Diet and β-Hydroxybutyrate: Novel Approaches to Adjuvant Brain Tumor Therapy. Frontiers in Molecular Neuroscience. 9. 122–122. 91 indexed citations
10.
Woolf, Eric C., et al.. (2016). Abstract 1670: Radiosensitization of glioma cells by the ketone body β-hydroxybutyrate is associated with enhanced cell cycle arrest in the G2/M phase. Cancer Research. 76(14_Supplement). 1670–1670. 1 indexed citations
11.
Ampie, Leonel, Eric C. Woolf, & Christopher Dardis. (2015). Immunotherapeutic Advancements for Glioblastoma. Frontiers in Oncology. 5. 12–12. 35 indexed citations
13.
Woolf, Eric C., et al.. (2015). Abstract 3346: The ketone body β-hydroxybutyrate increases radiosensitivity in glioma cell lines in vitro. Cancer Research. 75(15_Supplement). 3346–3346. 6 indexed citations
14.
Woolf, Eric C., et al.. (2015). ATPS-77THE KETONE BODY ß-HYDROXYBUTYRATE RADIOSENSITIZES GLIOBLASTOMA MULTIFORME STEM CELLS. Neuro-Oncology. 17(suppl 5). v35.2–v35. 1 indexed citations
15.
Pázmándi, Júlia, Kevin O’Neill, Adrienne C. Scheck, et al.. (2015). Abstract 240: The ketogenic diet alters the expression of microRNAs that play key roles in tumor development. Cancer Research. 75(15_Supplement). 240–240. 3 indexed citations
16.
Woolf, Eric C. & Adrienne C. Scheck. (2014). The ketogenic diet for the treatment of malignant glioma. Journal of Lipid Research. 56(1). 5–10. 69 indexed citations
17.
Woolf, Eric C., Phillip Stafford, Mohammed G. Abdelwahab, et al.. (2013). Abstract 4441: The ketogenic diet potentiates radiation therapy in a mouse model of glioma: effects on inflammatory pathways and reactive oxygen species.. Cancer Research. 73(8_Supplement). 4441–4441. 2 indexed citations
18.
Abdelwahab, Mohammed G., Eric C. Woolf, Kathryn E. Fenton, et al.. (2012). Abstract 3217: Mechanistic analysis of the ketogenic diet versus KetoCal® as adjuvant treatments for malignant glioma. Cancer Research. 72(8_Supplement). 3217–3217. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026